PIK3CA-related overgrowth spectrum (PROS) presenting as isolated macrodactyly

被引:1
|
作者
Krishnamurthy, Kritika [1 ,4 ]
Edema, Ukuemi [1 ]
Ustun, Berrin [1 ,2 ]
Villanueva-Siles, Esperanza [1 ,2 ]
Koehler, Steven M. [2 ,3 ]
Naeem, Rizwan [1 ,2 ]
Wang, Yanhua [1 ,2 ]
Goldstein, Doctor Y. [1 ,2 ]
机构
[1] Montefiore Med Ctr, Dept Pathol, Bronx, NY 10467 USA
[2] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA
[3] Montefiore Med Ctr, Dept Orthoped Surg, Bronx, NY 10467 USA
[4] Montefiore Med Ctr, Dept Mol Pathol, 1635 Poplar St, Bronx, NY 10462 USA
来源
JOURNAL OF SURGICAL CASE REPORTS | 2023年 / 2023卷 / 10期
关键词
PIK3CA-related overgrowth spectrum; PROS; macrodactyly; PIK3CA; mTOR pathway; mTOR inhibitors;
D O I
10.1093/jscr/rjad549
中图分类号
R61 [外科手术学];
学科分类号
摘要
PIK3CA-related overgrowth spectrum (PROS) is a heterogeneous group of diseases, with varied clinical presentations ranging from isolated segmental overgrowths to megalencephaly and vascular malformations, all resulting from post-zygotic activating mutations in PIK3CA. Isolated macrodactyly of upper limb is extremely rare, accounting only for 0.9%-1% of all congenital anomalies of the upper limb. This report describes a case of congenital, isolated, nonprogressive macrodactyly of the right index finger and thumb, in an adult patient that was treated with debulking surgery. The microscopic features were compatible with lipomatosis of nerve. Due to the prompt and pertinent molecular testing, which identified a somatic PIK3CA variant, c.3140A > G, p.H1047R., the case was classified as a PROS. The availability of mTOR inhibitors offers additional treatment possibilities in cases with progressive disease. This case report highlights the importance of molecular testing to identify PROS, to further the knowledge of this continually expanding entity.
引用
收藏
页数:4
相关论文
共 37 条
  • [31] A review of mechanisms of disease across PIK3CA-related disorders with vascular manifestations
    Guillaume Canaud
    Adrienne M. Hammill
    Denise Adams
    Miikka Vikkula
    Kim M. Keppler-Noreuil
    Orphanet Journal of Rare Diseases, 16
  • [32] Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)-related overgrowth spectrum: A brief report
    Denorme, Pieter
    Morren, Marie-Anne
    Hollants, Silke
    Spaepen, Marijke
    Suaer, Kate
    Zutterman, Nele
    Labarque, Veerle
    Legius, Eric
    Brems, Hilde
    PEDIATRIC DERMATOLOGY, 2018, 35 (03) : E186 - E188
  • [33] A somatic PIK3CA p.H1047L mutation in a Thai patient with isolated macrodactyly: a case report
    Udomchaiprasertkul, Wandee
    Kitidumrongsook, Pravit
    Suphapeetiporn, Kanya
    Shotelersuk, Vorasuk
    ASIAN BIOMEDICINE, 2019, 13 (01) : 33 - 36
  • [34] Early activating somatic PIK3CA mutations promote ectopic muscle development and upper limb overgrowth
    Frisk, Sofia
    Taylan, Fulya
    Blaszczyk, Izabela
    Nennesmo, Inger
    Anneren, Goran
    Herm, Bettina
    Stattin, Eva-Lena
    Zachariadis, Vasilios
    Lindstrand, Anna
    Tesi, Bianca
    Laurell, Tobias
    Nordgren, Ann
    CLINICAL GENETICS, 2019, 96 (02) : 118 - 125
  • [35] Germline pathogenic variant in PIK3CA leading to symmetrical overgrowth with marked macrocephaly and mild global developmental delay
    Zollino, Marcella
    Ranieri, Carlotta
    Grossi, Valentina
    Leoni, Chiara
    Lattante, Serena
    Mazza, Daniela
    Simone, Cristiano
    Resta, Nicoletta
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2019, 7 (08):
  • [36] Cerebellar dysplasia related to PIK3CA mutation: a three-case series
    Martina Di Stasi
    Giana Izzo
    Elisa Cattaneo
    Vittoria Baraldini
    Chiara Doneda
    Andrea Righini
    Daniela Graziani
    Valentina Toto
    Cecilia Parazzini
    neurogenetics, 2021, 22 : 27 - 32
  • [37] Intracranial venous malformation masquerading as a meningioma in PI3KCA-related overgrowth spectrum disorder
    Filippidis, Aristotelis
    Lidov, Hart
    Al-Ibraheemi, Alyaa
    See, Alfred P.
    Srivastava, Siddharth
    Orbach, Darren B.
    Fehnel, Katie Pricola
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2022, 188 (03) : 907 - 910